First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis

A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial

(2014) Gaelle Olivier et al.   AMERICAN JOURNAL OF HEMATOLOGY

Challenges in the treatment of elderly patients with primary central nervous system lymphoma

(2014) Patrick Roth et al.   CURRENT OPINION IN NEUROLOGY

Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience

(2014) Keishi Makino et al.   International Journal of Clinical Oncology

Prognosis Factors in Japanese Elderly Patients with Primary Central Nervous System Lymphoma Treated with a Nonradiation, Intermediate-Dose Methotrexate-Containing Regimen

(2014) Suk-young Lee et al.   Oncology Research and Treatment

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

(2013) Patrick G. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

(2013) James L. Rubenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center

(2012) M. R. Welch et al.   NEURO-ONCOLOGY

Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial

(2012) P. Roth et al.   NEUROLOGY

Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly

(2011) K. Fritsch et al.   ANNALS OF ONCOLOGY

Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination

(2011) A. J. M. Ferreri et al.   ONCOLOGIST

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis

(2010) Mascha Schuurmans et al.   BRITISH JOURNAL OF HAEMATOLOGY

Characteristics and outcomes of elderly patients with primary central nervous system lymphoma

(2010) Douglas E. Ney et al.   CANCER

Treatment approaches for primary CNS lymphomas

(2010) Matteo G Carrabba et al.   EXPERT OPINION ON PHARMACOTHERAPY

A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma

(2010) Kennichi Taoka et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

(2010) Eckhard Thiel et al.   LANCET ONCOLOGY

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

(2009) H. Ghesquieres et al.   ANNALS OF ONCOLOGY

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

(2009) Delia Kurzwelly et al.   JOURNAL OF NEURO-ONCOLOGY

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

(2009) Andrés JM Ferreri et al.   LANCET

Therapeutic challenges in primary CNS lymphoma

(2009) Patrick G Morris et al.   LANCET NEUROLOGY

Primary CNS Lymphoma in Immunocompetent Patients

(2009) M. Sierra del Rio et al.   ONCOLOGIST

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study

(2008) G. Illerhaus et al.   ANNALS OF ONCOLOGY

Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy

(2008) Meltem Ekenel et al.   CANCER

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

(2008) Michael Pfreundschuh et al.   LANCET ONCOLOGY

High-dose methotrexate for elderly patients with primary CNS lymphoma

(2008) Jay-Jiguang Zhu et al.   NEURO-ONCOLOGY